Mehlyumyna akrydonatsetat | Cycloferon tablets 150 mg, 50 pcs
Special Price
$29.40
Regular Price
$37.00
In stock
SKU
BID462373
Release form
film-coated tablets.
film-coated tablets.
Release form
film-coated tablets.
Packing
50 pcs.
Pharmacological action
Immunostimulating, antiviral, anti-inflammatory
Cycloferon is a low molecular weight inducer of interferon, which determines a wide range of its pharmacological activity (antiviral, immunomodulating, anti-inflammatory, etc.).
The main producing cells of interferon after Cycloferon administration are macrophages, T-lymphocytes, B-lymphocytes, fibroblasts, epithelial cells. Depending on the type of infection, one or another link in the immune system is activated. The drug induces high titers of interferon in organs and tissues containing lymphoid elements (spleen, liver, lungs), activates bone marrow stem cells, stimulating the formation of granulocytes. Cycloferon activates T-lymphocytes and natural killer cells, normalizes the balance between subpopulations of T-helpers and T-suppressors. Overcomes the blood-brain barrier.
Cycloferon is effective against tick-borne encephalitis, influenza, hepatitis, herpes, cytomegalovirus, human immunodeficiency virus, papilloma virus and other viruses.
The drug has been found to be highly effective in the complex treatment of acute and chronic bacterial infections (chlamydia, erysipelas, bronchitis, pneumonia, postoperative complications, bacterial and fungal infections of the genitourinary tract, peptic ulcer) as a component of immunotherapy.
Cycloferon is highly effective in rheumatic and systemic diseases of the connective tissue, suppressing autoimmune reactions and providing anti-inflammatory and analgesic effects.
The immunomodulatory effect of cycloferon is expressed in the activation of phagocytosis, natural killer cells, cytotoxic T-lymphocytes and correction of the body's immune status in immunodeficiency and autoimmune conditions of various origins.
Indications
In adults and children from four years of age in the complex therapy:
- influenza and acute respiratory diseases
- herpetic infections.
Contraindications
Pregnancy, lactation, children under 4 years of age (due to imperfect swallowing), individual intolerance to the components of the drug, decompensated liver cirrhosis.
With caution: For diseases of the digestive system in the acute stage (erosion, gastric and / or duodenal ulcers, gastritis and duodenitis) and a history of allergic reactions, be sure to consult your doctor before taking the drug.
Use during pregnancy and lactation
Contraindicated.
Special instructions
For diseases of the thyroid gland, consultation with an endocrinologist is necessary.
If the next dose of the drug is missed, then as soon as possible without taking into account the time interval and doubling the dosage, continue the course according to the scheme begun.
In the absence of a therapeutic effect, consult a doctor.
Composition
1 tablet contains meglumine acridone acetate in terms of acridonoacetic acid - 150 mg
excipients: povidone, calcium stearate, hypromellose, polysorbate 80, methacrylic acid and ethyl acrylate copolymer, propylene glycol.
Dosage and administration
Inside, once a day, 30 minutes before meals, without chewing, drinking 1/2 cup of water, in age dosages: for children 4-6 years old: 150 mg (1 tablet) per day for children 7-11 years old: 300-450 mg (2-3 tablets) per adult and children over 12 years of age: 450-600 (3-4 tablets) per admission.
It is advisable to take the second course 2-3 weeks after the end of the first course.
In adults:
1. In the treatment of influenza and acute respiratory infections, the drug is taken on the 1st, 2nd, 4th, 6th, 8th day (course of treatment - 20 tablets). Treatment should be started at the first symptoms of the disease.
In severe cases of flu on the first day, take six tablets. If necessary, additional symptomatic therapy (antipyretic, analgesic, expectorant drugs).
2. In case of herpes infection, the drug is taken on 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 days (course of treatment 40 tablets). Treatment is most effective when the first symptoms of the disease appear.
In children from the age of four:
1. For influenza and acute respiratory infections, the drug is taken in age doses on 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 days. The course of treatment is from 5 to 10 doses, depending on the severity of the condition and the severity of clinical symptoms.
2. In case of herpes infection, the drug is taken on the 1st, 2nd, 4th, 6th, 8th, 11th, 14th day of treatment. The course of treatment may vary depending on the severity of the condition and the severity of clinical symptoms.
3. For emergency non-specific prophylaxis of influenza and acute respiratory infections (in direct contact with patients with influenza or acute respiratory infections of other etiologies during the flu epidemic): on days 1, 2, 4, 6, 8. Then they take a break of 72 hours (three days) and continue the course for 11, 14, 17, 20, 23 days. The general course is from 5 to 10 receptions.
Side effects
Allergic reactions.
Drug Interactions
Cycloferon is compatible with all drugs used in the treatment of these diseases (interferons, chemotherapeutic, symptomatic drugs, etc.). Enhances the action of interferons and nucleoside analogues. Reduces the side effects of chemotherapy, interferon therapy.
Storage conditions
Store in a dry, dark place out of the reach of children at temperatures not exceeding 25 C.
Expiration
2 years.
Active ingredient
Meglumine acridone acetate
Conditions of dispatch from
pharmacies Without prescription
Dosage form
tablet
film-coated tablets.
Packing
50 pcs.
Pharmacological action
Immunostimulating, antiviral, anti-inflammatory
Cycloferon is a low molecular weight inducer of interferon, which determines a wide range of its pharmacological activity (antiviral, immunomodulating, anti-inflammatory, etc.).
The main producing cells of interferon after Cycloferon administration are macrophages, T-lymphocytes, B-lymphocytes, fibroblasts, epithelial cells. Depending on the type of infection, one or another link in the immune system is activated. The drug induces high titers of interferon in organs and tissues containing lymphoid elements (spleen, liver, lungs), activates bone marrow stem cells, stimulating the formation of granulocytes. Cycloferon activates T-lymphocytes and natural killer cells, normalizes the balance between subpopulations of T-helpers and T-suppressors. Overcomes the blood-brain barrier.
Cycloferon is effective against tick-borne encephalitis, influenza, hepatitis, herpes, cytomegalovirus, human immunodeficiency virus, papilloma virus and other viruses.
The drug has been found to be highly effective in the complex treatment of acute and chronic bacterial infections (chlamydia, erysipelas, bronchitis, pneumonia, postoperative complications, bacterial and fungal infections of the genitourinary tract, peptic ulcer) as a component of immunotherapy.
Cycloferon is highly effective in rheumatic and systemic diseases of the connective tissue, suppressing autoimmune reactions and providing anti-inflammatory and analgesic effects.
The immunomodulatory effect of cycloferon is expressed in the activation of phagocytosis, natural killer cells, cytotoxic T-lymphocytes and correction of the body's immune status in immunodeficiency and autoimmune conditions of various origins.
Indications
In adults and children from four years of age in the complex therapy:
- influenza and acute respiratory diseases
- herpetic infections.
Contraindications
Pregnancy, lactation, children under 4 years of age (due to imperfect swallowing), individual intolerance to the components of the drug, decompensated liver cirrhosis.
With caution: For diseases of the digestive system in the acute stage (erosion, gastric and / or duodenal ulcers, gastritis and duodenitis) and a history of allergic reactions, be sure to consult your doctor before taking the drug.
Use during pregnancy and lactation
Contraindicated.
Special instructions
For diseases of the thyroid gland, consultation with an endocrinologist is necessary.
If the next dose of the drug is missed, then as soon as possible without taking into account the time interval and doubling the dosage, continue the course according to the scheme begun.
In the absence of a therapeutic effect, consult a doctor.
Composition
1 tablet contains meglumine acridone acetate in terms of acridonoacetic acid - 150 mg
excipients: povidone, calcium stearate, hypromellose, polysorbate 80, methacrylic acid and ethyl acrylate copolymer, propylene glycol.
Dosage and administration
Inside, once a day, 30 minutes before meals, without chewing, drinking 1/2 cup of water, in age dosages: for children 4-6 years old: 150 mg (1 tablet) per day for children 7-11 years old: 300-450 mg (2-3 tablets) per adult and children over 12 years of age: 450-600 (3-4 tablets) per admission.
It is advisable to take the second course 2-3 weeks after the end of the first course.
In adults:
1. In the treatment of influenza and acute respiratory infections, the drug is taken on the 1st, 2nd, 4th, 6th, 8th day (course of treatment - 20 tablets). Treatment should be started at the first symptoms of the disease.
In severe cases of flu on the first day, take six tablets. If necessary, additional symptomatic therapy (antipyretic, analgesic, expectorant drugs).
2. In case of herpes infection, the drug is taken on 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 days (course of treatment 40 tablets). Treatment is most effective when the first symptoms of the disease appear.
In children from the age of four:
1. For influenza and acute respiratory infections, the drug is taken in age doses on 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 days. The course of treatment is from 5 to 10 doses, depending on the severity of the condition and the severity of clinical symptoms.
2. In case of herpes infection, the drug is taken on the 1st, 2nd, 4th, 6th, 8th, 11th, 14th day of treatment. The course of treatment may vary depending on the severity of the condition and the severity of clinical symptoms.
3. For emergency non-specific prophylaxis of influenza and acute respiratory infections (in direct contact with patients with influenza or acute respiratory infections of other etiologies during the flu epidemic): on days 1, 2, 4, 6, 8. Then they take a break of 72 hours (three days) and continue the course for 11, 14, 17, 20, 23 days. The general course is from 5 to 10 receptions.
Side effects
Allergic reactions.
Drug Interactions
Cycloferon is compatible with all drugs used in the treatment of these diseases (interferons, chemotherapeutic, symptomatic drugs, etc.). Enhances the action of interferons and nucleoside analogues. Reduces the side effects of chemotherapy, interferon therapy.
Storage conditions
Store in a dry, dark place out of the reach of children at temperatures not exceeding 25 C.
Expiration
2 years.
Active ingredient
Meglumine acridone acetate
Conditions of dispatch from
pharmacies Without prescription
Dosage form
tablet
Write Your Own Review